ProCure21 Key Performance Indicators show that over the past 5 years ProCure21 clients are very satisfied with their final product and service received. General defects are minor, safety figures are above industry average and cost and time predictability figures show good performance.

Other indicators show that ProCure21 schemes are no more expensive than traditionally procured schemes and significant cost savings can be made through a shorter tender and construction time periods.

Year on year performance figures

Footnotes

1. Cost and time predictability takes account of the effects of client changes (compensation events).
2. Results based on an analysis of completed P21 Schemes over £1 million Guaranteed Maximum Price.

Comparing costs

How ProCure21 out-turn costs compare with traditional* contracting over a range of clinical facility types.

All costs shown are per m² gross internal floor area and at MIPS 489 and location factor 1.00.

All costs exclude demolition and site preparation, site abnormals, external works, Group 2,3&4 fittings and equipment, professional fees, contingency and VAT.

* Building Cost Information Service - Royal Institution of Chartered Surveyors.

Other cost savings

ProCure21 contracts are not required to be advertised in accordance with EU rules. This provides an average estimated time saving of six months per contract. The BCIS survey of tender prices (Q4-2007) forecasted a tender price rise of 5.1%. A six month time saving would therefore equate to approximately 2.55% capital cost saving over this period.

Analysis of ProCure21 schemes show comparatively shorter construction periods - 7 weeks for schemes between £1-5m and 17weeks for schemes between £5-15m. This could equate to cost savings of approximately 1% of capital cost depending on changing tender index figures.